sattva neelapu, md, discusses the results of the zuma-1 pivotal phase 2 study with kte-c19
Published 7 years ago • 42 plays • Length 1:03
Download video MP4
Download video MP3
Similar videos
-
0:55
frederick l. locke, md, discusses the results of the zuma-1 pivotal phase 2 study with kte-c19
-
1:17
sattva neelapu, md, explains what the results of zuma-1 mean to dlbcl patients
-
0:32
sattva neelapu, md shares safety results of the zuma-1 trial in patients with nhl
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
1:18
sattva neelapu, md, tells us about the results of the zuma-1 study in dlbcl presented at ash 2019
-
1:41
sattva neelapu, md, regarding the zuma-1 two-year follow-up study in dlbcl
-
6:21
sattva s. neelapu, md: encouraging results for car t-cells in refractory dlbcl
-
2:08
acrylamide acute neurotoxicity in adult zebrafish
-
3:41
interim results from the zuma-1 trial of novel car-t cells against non-hodgkin lymphoma
-
7:06
dlbcl: car-t as curative treatment/bridge to transplant
-
0:53
dr. neelapu on next steps with kte-c19 in lymphoma
-
1:33
sattva neelapu, md, on real-world experience & clinical studies examining axicabtagene ciloleucel
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
2:02
dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma
-
2:13
sattva neelapu | ash 2018 | results from the two-year follow-up of zuma-1
-
4:19
the pivotal zuma-1 trial for nhl
-
0:46
key takeaway from 2-year follow-up data of zuma-1 trial in large b-cell lymphoma
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
1:01
sattva neelapu, md, on the possibility to enhance t-cell proliferation for a higher response rate
-
1:37
sattva neelapu, md, considers the use of axicabtagene ciloleucel with elderly lymphoma patients
-
1:16
sattva neelapu: zuma-14
Clip.africa.com - Privacy-policy